|
A more recent version of this article appeared on November 11, 2005
Papers In Press, published online ahead of print September 14, 2005
J. Biol. Chem, 10.1074/jbc.M508246200
Submitted on July 27, 2005
Revised on September 12, 2005
Accepted on September 14, 2005
Resveratrol promotes clearance of Alzheimer's disease amyloid- peptides
Philippe Marambaud, Haitian Zhao, and Peter Davies
The Litwin-Zucker Research Center for the Study of Alzheimers Disease and Memory Disorders, North Shore-LIJ Institute for Medical Research, Manhasset, NY 11030
Corresponding Author: pmaramba{at}aecom.yu.edu
Several epidemiological studies indicate that moderate consumption of wine is associated with a lower incidence of Alzheimers disease. Wine is enriched in antioxidant compounds with potential neuroprotective activities. However, the exact molecular mechanisms involved in the beneficial effects of wine intake on the neurodegenerative process in Alzheimers disease brain, remains to be clearly defined. Here we show that resveratrol (trans-3,4',5-trihydroxystilbene), a naturally occurring polyphenol mainly found in grapes and red wine, markedly lowers the levels of secreted and intracellular amyloid- (A ) peptides produced from different cell lines. Resveratrol does not inhibit A production, since it has no effect on the A -producing enzymes - and -secretases, but promotes instead intracellular degradation of A via a mechanism that involves the proteasome. Indeed, the resveratrol-induced decrease of A could be prevented by several selective proteasome inhibitors and by siRNA-directed silencing of the proteasome subunit 5. These findings demonstrate a proteasome-dependent anti-amyloidogenic activity of resveratrol and suggest that this natural compound has a therapeutic potential in Alzheimers disease.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. SALLOWAY and S. CORREIA
Alzheimer disease: Time to improve its diagnosis and treatment
Cleveland Clinic Journal of Medicine,
January 1, 2009;
76(1):
49 - 58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ono, M. M. Condron, L. Ho, J. Wang, W. Zhao, G. M. Pasinetti, and D. B. Teplow
Effects of Grape Seed-derived Polyphenols on Amyloid {beta}-Protein Self-assembly and Cytotoxicity
J. Biol. Chem.,
November 21, 2008;
283(47):
32176 - 32187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Onozuka, A. Nakajima, K. Matsuzaki, R.-W. Shin, K. Ogino, D. Saigusa, N. Tetsu, A. Yokosuka, Y. Sashida, Y. Mimaki, et al.
Nobiletin, a Citrus Flavonoid, Improves Memory Impairment and A{beta} Pathology in a Transgenic Mouse Model of Alzheimer's Disease
J. Pharmacol. Exp. Ther.,
September 1, 2008;
326(3):
739 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Catoire, M. Y. Pasco, A. Abu-Baker, S. Holbert, C. Tourette, B. Brais, G. A. Rouleau, J. A. Parker, and C. Neri
Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1
Hum. Mol. Genet.,
July 15, 2008;
17(14):
2108 - 2117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bacher, R. Dodel, B. Aljabari, K. Keyvani, P. Marambaud, R. Kayed, C. Glabe, N. Goertz, A. Hoppmann, N. Sachser, et al.
CNI-1493 inhibits A{beta} production, plaque formation, and cognitive deterioration in an animal model of Alzheimer's disease
J. Exp. Med.,
July 7, 2008;
205(7):
1593 - 1599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. Ho, W. Zhao, K. Ono, C. Rosensweig, L. Chen, N. Humala, D. B. Teplow, and G. M. Pasinetti
Grape-Derived Polyphenolics Prevent A{beta} Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease
J. Neurosci.,
June 18, 2008;
28(25):
6388 - 6392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. Ho, Z. Zhao, I. Seror, N. Humala, D. L. Dickstein, M. Thiyagarajan, S. S. Percival, S. T. Talcott, and G. M. Pasinetti
Moderate consumption of Cabernet Sauvignon attenuates A{beta} neuropathology in a mouse model of Alzheimer's disease
FASEB J,
November 1, 2006;
20(13):
2313 - 2320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Masters and K. Beyreuther
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway
Brain,
November 1, 2006;
129(11):
2823 - 2839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Weissmann
Dietary supplements: red wine, ortolans, and chondroitin sulfate
FASEB J,
May 1, 2006;
20(7):
803 - 805.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|